{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:29:08Z","timestamp":1781803748087,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1-3","license":[{"start":{"date-parts":[[2015,8,30]],"date-time":"2015-08-30T00:00:00Z","timestamp":1440892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12026-015-8688-3","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T04:43:49Z","timestamp":1440823429000},"page":"90-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes"],"prefix":"10.1007","volume":"63","author":[{"given":"Brian A.","family":"McCarthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Yancopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Tipping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Catera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley T.","family":"Messmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Cutrona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manlio","family":"Ferrarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Kolitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanti R.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Rawstron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Chiorazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,30]]},"reference":[{"key":"8688_CR1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","volume":"352","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi N, Rai KR, Ferrarini M. Chronic Lymphocytic leukemia. N Engl J Med. 2005;352:804\u201315.","journal-title":"N Engl J Med"},{"key":"8688_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc2764","volume":"10","author":"T Zenz","year":"2010","unstructured":"Zenz T, Mertens D, Kuppers R, Dohner H, Stilgenbauer S. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer. 2010;10:37\u201350.","journal-title":"Nat Rev Cancer"},{"key":"8688_CR3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ajh.23979","volume":"90","author":"M Hallek","year":"2015","unstructured":"Hallek M. Chronic lymphocytic leukemia: 2015 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2015;90:446\u201360.","journal-title":"Am J Hematol"},{"key":"8688_CR4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJMoa0806122","volume":"360","author":"O Landgren","year":"2009","unstructured":"Landgren O, Albitar M, Ma W, et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med. 2009;360:659\u201367.","journal-title":"N Engl J Med"},{"key":"8688_CR5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/ajh.21854","volume":"85","author":"M Frezzato","year":"2010","unstructured":"Frezzato M, Giaretta I, Madeo D, Rodeghiero F. Identical IGHV-D-J gene rearrangement may precede the clinical onset of chronic lymphocytic leukemia by several years. Am J Hematol. 2010;85:868\u201371.","journal-title":"Am J Hematol"},{"key":"8688_CR6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.V100.2.635","volume":"100","author":"AC Rawstron","year":"2002","unstructured":"Rawstron AC, Green MJ, Kuzmicki A, et al. Monoclonal B lymphocytes with the characteristics of \u201cindolent\u201d chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002;100:635\u20139.","journal-title":"Blood"},{"key":"8688_CR7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.seminhematol.2004.05.001","volume":"41","author":"A Rawstron","year":"2004","unstructured":"Rawstron A, Hillmen P, Houlston R. Clonal lymphocytes in persons without known chronic lymphocytic leukemia (CLL): implications of recent findings in family members of CLL patients. Semin Hematol. 2004;41:192\u2013200.","journal-title":"Semin Hematol"},{"key":"8688_CR8","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2003-09-3277","volume":"103","author":"P Ghia","year":"2004","unstructured":"Ghia P, Prato G, Scielzo C, et al. Monoclonal CD5+ and CD5\u2212 B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood. 2004;103:2337\u201342.","journal-title":"Blood"},{"key":"8688_CR9","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood-2004-01-0341","volume":"104","author":"LR Goldin","year":"2004","unstructured":"Goldin LR, Pfeiffer RM, Li X, Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood. 2004;104:1850\u20134.","journal-title":"Blood"},{"key":"8688_CR10","doi-asserted-by":"crossref","unstructured":"Goldin LR, Bjorkholm M, Kristinsson SY, Turesson I, Landgren O. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin\u2019s lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica. 2009. doi: 10.3324\/haematol.2008.003632","DOI":"10.3324\/haematol.2008.003632"},{"key":"8688_CR11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJMoa075290","volume":"359","author":"AC Rawstron","year":"2008","unstructured":"Rawstron AC, Bennett FL, O\u2019Connor SJ, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008;359:575\u201383.","journal-title":"N Engl J Med"},{"key":"8688_CR12","doi-asserted-by":"crossref","unstructured":"Shanafelt TD, Kay NE, Jenkins G, et al. B-cell count and survival: Differentiating chronic lymphocytic leukemia (CLL) from monoclonal B-cell lymphocytosis (MBL) based on clinical outcome. Blood. 2008. doi: 10.1182\/blood-2008-09-176149 .","DOI":"10.1182\/blood-2008-09-176149"},{"key":"8688_CR13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","volume":"134","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance. Br J Haematol. 2006;134:573\u201389.","journal-title":"Br J Haematol"},{"key":"8688_CR14","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","volume":"117","author":"N Chiorazzi","year":"2011","unstructured":"Chiorazzi N, Ferrarini M. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood. 2011;117:1781\u201391.","journal-title":"Blood"},{"key":"8688_CR15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/leu.2009.287","volume":"24","author":"TD Shanafelt","year":"2010","unstructured":"Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia. 2010;24:512\u201320.","journal-title":"Leukemia"},{"key":"8688_CR16","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/eji.1830260911","volume":"26","author":"M Dono","year":"1996","unstructured":"Dono M, Burgio VL, Tacchetti C, et al. Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization. Eur J Immunol. 1996;26:2035\u201342.","journal-title":"Eur J Immunol"},{"key":"8688_CR17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1073\/pnas.98.1.31","volume":"98","author":"C Li","year":"2001","unstructured":"Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA. 2001;98:31\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8688_CR18","doi-asserted-by":"crossref","DOI":"10.1002\/9781118548387","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2013","unstructured":"Hosmer DW, Lemeshow S. Applied logistic regression. Hoboken: Wiley; 2013."},{"key":"8688_CR19","first-page":"211","volume":"1","author":"ME Tipping","year":"2001","unstructured":"Tipping ME. Sparse Bayesian learning and the relevance vector machine. J Mach Learn Res. 2001;1:211\u201344.","journal-title":"J Mach Learn Res"},{"key":"8688_CR20","first-page":"18","volume":"2","author":"A Liaw","year":"2002","unstructured":"Liaw A, Wiener M. Classification and regression by random forest. R News. 2002;2:18\u201322.","journal-title":"R News"},{"key":"8688_CR21","first-page":"346","volume":"1","author":"DF Jelinek","year":"2003","unstructured":"Jelinek DF, Tschumper RC, Stolovitzky GA, et al. Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Mol Cancer Res. 2003;1:346\u201361.","journal-title":"Mol Cancer Res"},{"key":"8688_CR22","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","volume":"194","author":"A Rosenwald","year":"2001","unstructured":"Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194:1639\u201347.","journal-title":"J Exp Med"},{"key":"8688_CR23","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","volume":"194","author":"U Klein","year":"2001","unstructured":"Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194:1625\u201338.","journal-title":"J Exp Med"},{"key":"8688_CR24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI28281","volume":"117","author":"V Del Gaizo Moore","year":"2007","unstructured":"Del Gaizo Moore V, Brown JR, Certo M, Love TM, Novina CD, Letai A. Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J Clin Invest. 2007;117:112\u201321.","journal-title":"J Clin Invest."},{"key":"8688_CR25","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1093\/bioinformatics\/bti487","volume":"21","author":"S Rogers","year":"2005","unstructured":"Rogers S, Girolami M. A Bayesian regression approach to the inference of regulatory networks from gene expression data. Bioinformatics. 2005;21:3131\u20137.","journal-title":"Bioinformatics"},{"key":"8688_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmpb.2008.05.002","volume":"92","author":"W Zhang","year":"2008","unstructured":"Zhang W, Liu J, Niu YQ, Wang L, Hu X. A Bayesian regression approach to the prediction of MHC-II binding affinity. Comput Methods Programs Biomed. 2008;92:1\u20137.","journal-title":"Comput Methods Programs Biomed"},{"key":"8688_CR27","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1021\/ci034160g","volume":"43","author":"V Svetnik","year":"2003","unstructured":"Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, Feuston BP. Random forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci. 2003;43:1947\u201358.","journal-title":"J Chem Inf Comput Sci"},{"key":"8688_CR28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2141.2007.06865.x","volume":"139","author":"G Marti","year":"2007","unstructured":"Marti G, Abbasi F, Raveche E, et al. Overview of monoclonal B-cell lymphocytosis. Br J Haematol. 2007;139:701\u20138.","journal-title":"Br J Haematol"},{"key":"8688_CR29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/10428190902763483","volume":"50","author":"T Shanafelt","year":"2009","unstructured":"Shanafelt T, Hanson CA. Monoclonal B-cell lymphocytosis: definitions and natural history. Leuk Lymphoma. 2009;50:493\u20137.","journal-title":"Leuk Lymphoma"},{"key":"8688_CR30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07711.x","volume":"146","author":"D Rossi","year":"2009","unstructured":"Rossi D, Sozzi E, Puma A, De Paoli L, Rasi S, Spina V, Gozzetti A, Tassi M, Cencini E, Raspadori D, Pinto V, Bertoni F, Gattei V, Lauria F, Gaidano G, Forconi F. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol. 2009;146:64\u201375.","journal-title":"Br J Haematol"},{"key":"8688_CR31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CMR.19.1.165-256.2006","volume":"19","author":"MJ Espy","year":"2006","unstructured":"Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev. 2006;19:165\u2013256.","journal-title":"Clin Microbiol Rev"},{"key":"8688_CR32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1473-3099(04)01044-8","volume":"4","author":"S Yang","year":"2004","unstructured":"Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis. 2004;4:337\u201348.","journal-title":"Lancet Infect Dis"},{"key":"8688_CR33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00004424-197903000-00002","volume":"14","author":"JA Swets","year":"1979","unstructured":"Swets JA. ROC analysis applied to the evaluation of medical imaging techniques. Invest Radiol. 1979;14:109\u201321.","journal-title":"Invest Radiol"},{"key":"8688_CR34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/0272989X8400400203","volume":"4","author":"BJ McNeil","year":"1984","unstructured":"McNeil BJ, Hanley JA. Statistical approaches to the analysis of receiver operating characteristic (ROC) curves. Med Decis Mak. 1984;4:137\u201350.","journal-title":"Med Decis Mak"},{"key":"8688_CR35","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1158\/1078-0432.CCR-13-0622","volume":"19","author":"F Morabito","year":"2013","unstructured":"Morabito F, Mosca L, Cutrona G, et al. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: a comparison of cellular, cytogenetic, molecular, and clinical features. Clin Cancer Res. 2013;19:5890\u2013900.","journal-title":"Clin Cancer Res"},{"key":"8688_CR36","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2004-04-1233","volume":"105","author":"C Mayr","year":"2005","unstructured":"Mayr C, Bund D, Schlee M, et al. Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. Blood. 2005;105:1566\u201373.","journal-title":"Blood"},{"key":"8688_CR37","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/leu.2008.29","volume":"22","author":"I Hus","year":"2008","unstructured":"Hus I, Schmitt M, Tabarkiewicz J, et al. Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response. Leukemia. 2008;22:1007\u201317.","journal-title":"Leukemia"},{"key":"8688_CR38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.coph.2005.03.002","volume":"5","author":"L Stephens","year":"2005","unstructured":"Stephens L, Williams R, Hawkins P. Phosphoinositide 3-kinases as drug targets in cancer. Curr Opin Pharmacol. 2005;5:357\u201365.","journal-title":"Curr Opin Pharmacol"},{"key":"8688_CR39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6890-3-4","volume":"3","author":"SS Sheikh El","year":"2003","unstructured":"El Sheikh SS, Domin J, Tomtitchong P, Abel P, Stamp G, Lalani EN. Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation. BMC Clin Pathol. 2003;3:4.","journal-title":"BMC Clin Pathol"},{"key":"8688_CR40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1083\/jcb.200408005","volume":"169","author":"T Maffucci","year":"2005","unstructured":"Maffucci T, Cooke FT, Foster FM, Traer CJ, Fry MJ, Falasca M. Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration. J Cell Biol. 2005;169:789\u201399.","journal-title":"J Cell Biol"},{"key":"8688_CR41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/jcp.20478","volume":"205","author":"J Domin","year":"2005","unstructured":"Domin J, Harper L, Aubyn D, et al. The class II phosphoinositide 3-kinase PI3K-C2beta regulates cell migration by a PtdIns3P dependent mechanism. J Cell Physiol. 2005;205:452\u201362.","journal-title":"J Cell Physiol"},{"key":"8688_CR42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jcp.20507","volume":"206","author":"M Wheeler","year":"2006","unstructured":"Wheeler M, Domin J. The N-terminus of phosphoinositide 3-kinase-C2beta regulates lipid kinase activity and binding to clathrin. J Cell Physiol. 2006;206:586\u201393.","journal-title":"J Cell Physiol"},{"key":"8688_CR43","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1158\/1541-7786.MCR-07-0262","volume":"6","author":"W Elis","year":"2008","unstructured":"Elis W, Triantafellow E, Wolters NM, et al. Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death. Mol Cancer Res. 2008;6:614\u201323.","journal-title":"Mol Cancer Res"},{"key":"8688_CR44","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood-2007-05-089037","volume":"111","author":"PG Longo","year":"2008","unstructured":"Longo PG, Laurenti L, Gobessi S, Sica S, Leone G, Efremov DG. The Akt\/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood. 2008;111:846\u201355.","journal-title":"Blood"},{"key":"8688_CR45","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321:1807\u201312.","journal-title":"Science"},{"key":"8688_CR46","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1091\/mbc.E09-05-0390","volume":"20","author":"S Srivastava","year":"2009","unstructured":"Srivastava S, Di L, Zhdanova O, et al. The class II phosphatidylinositol 3 kinase C2\u03b2 is required for the activation of the K+ channel KCa3.1 and CD4 T-cells. Mol Biol Cell. 2009;20:3783\u201391.","journal-title":"Mol Biol Cell"},{"key":"8688_CR47","doi-asserted-by":"crossref","first-page":"20072","DOI":"10.1073\/pnas.1111233109","volume":"108","author":"X Cai","year":"2011","unstructured":"Cai X, Srivastava S, Sun Y, et al. Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2\u03b2. Proc Natl Acad Sci USA. 2011;108:20072\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8688_CR48","first-page":"395","volume":"19","author":"E Marras","year":"2001","unstructured":"Marras E, Concari P, Cortellezzi L, Dondi D, De Eguileor M, Perletti G. Involvement of PI3K in PKCepsilon-mediated oncogenic signal in rat colonic epithelial cells. Int J Oncol. 2001;19:395\u20139.","journal-title":"Int J Oncol"},{"key":"8688_CR49","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","volume":"101","author":"A Wiestner","year":"2003","unstructured":"Wiestner A, Rosenwald A, Barry TS, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 2003;101:4944\u201351.","journal-title":"Blood"},{"key":"8688_CR50","first-page":"846","volume":"12","author":"JR Brown","year":"2014","unstructured":"Brown JR. Idelalisib for chronic lymphocytic leukemia. Clin Adv Hematol Oncol. 2014;12:846\u20138.","journal-title":"Clin Adv Hematol Oncol"},{"key":"8688_CR51","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3109\/08830185.2013.786711","volume":"32","author":"T Robak","year":"2013","unstructured":"Robak T, Robak P. BCR signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies. Int Rev Immunol. 2013;32:358\u201376.","journal-title":"Int Rev Immunol"},{"key":"8688_CR52","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood-2010-02-269878","volume":"116","author":"A Gutierrez Jr","year":"2010","unstructured":"Gutierrez A Jr, Tschumper RC, Wu X, et al. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood. 2010;116:2975\u201383.","journal-title":"Blood"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-015-8688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-015-8688-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-015-8688-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:15:22Z","timestamp":1567124122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-015-8688-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,30]]},"references-count":52,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["8688"],"URL":"https:\/\/doi.org\/10.1007\/s12026-015-8688-3","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,30]]}}}